Biology
The term leukemia means “white blood,” a name originally used to describe the pale appearance of blood in patients with very high white blood cell counts before effective treatments were available.
Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the blood and bone marrow. It is characterized by an increased number of lymphocytes—a type of white blood cell. In CLL, these cells can build up in the blood and bone marrow and may accumulate in the lymph nodes, liver, and spleen, sometimes causing swelling or enlargement.
Most cases of CLL involve B lymphocytes (B cells), while a small percentage involve T lymphocytes. The reasons for these differences are still being studied.
How CLL Develops
Although the exact cause of CLL is not fully understood, it is known that genetic changes (mutations) in DNA lead to the production of abnormal lymphocytes. Unlike healthy cells, which grow and die in a controlled way, these abnormal cells live longer than they should and continue to accumulate.
Over time, CLL cells can crowd out healthy blood-forming cells in the bone marrow, which may lead to:
- Reduced normal white blood cells (affecting immune function)
- Low red blood cells (anemia)
- Low platelets (increased risk of bruising or bleeding)
Disease Behavior
CLL has traditionally been described as an indolent (slow-progressing) disease. While this is true for many patients, CLL can vary widely from person to person. Some individuals may live for years without needing treatment, while others experience a more aggressive disease course.
Advances in research have shown that CLL is not a single, uniform disease. Specific genetic and molecular features—often called prognostic markers—help doctors better understand how the disease may behave and guide treatment decisions.
The Role of the Microenvironment
CLL cells do not act alone. They exist within a “microenvironment” made up of surrounding cells and signaling molecules that support their growth and survival.
This interaction between CLL cells and their environment:
- Helps the cancer cells survive and multiply
- Can make them more resistant to treatment
Because of this, the microenvironment has become an important focus of research and a promising target for new therapies.
Looking Ahead
Our understanding of CLL biology continues to grow rapidly. These advances are leading to more personalized treatment approaches and improved outcomes for patients. What was once thought to be a uniform disease is now recognized as highly variable, allowing care to be better tailored to each individual.